Even though further investigaton is clearly needed, our preliminary data provide first hints that inactivation of ARID1A might not be sufficient to initiate tumor development, but that additional TP53 inactivation might be necessary to drive oncogenic transformation of urothelial cells. Here, TP53 is linked to neoplasm.